↓ Skip to main content

Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack

Overview of attention for article published in this source, January 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
46 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack
Published by
John Wiley & Sons, Ltd, January 2014
DOI 10.1002/14651858.cd010693.pub2
Pubmed ID
Authors

Liu, Jia, Wang, Lu-Ning

Abstract

Peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists are insulin-sensitising drugs used for the treatment of insulin resistance. In addition to lowing glucose in diabetes, these drugs may also protect against hyperlipidaemia and arteriosclerosis, which are risk factors for stroke.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 4%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 17%
Student > Master 7 15%
Student > Bachelor 5 11%
Student > Doctoral Student 4 9%
Other 4 9%
Other 10 22%
Unknown 8 17%
Readers by discipline Count As %
Medicine and Dentistry 22 48%
Biochemistry, Genetics and Molecular Biology 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Neuroscience 2 4%
Nursing and Health Professions 1 2%
Other 8 17%
Unknown 9 20%